Ετικέτες

Δευτέρα 1 Ιουλίου 2019

Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway
Background: Tanshinone IIA (Tan IIA) and Omentin-1 have a protective role in the cardiovascular system. However, if and how Tan IIA and Omentin-1 regulate cholesterol metabolism in macrophages has not been fully elucidated. Objective: To investigate the possible mechanisms of Tan IIA and Omentin-1 on preventing macrophage cholesterol accumulation and atherosclerosis development. Methods: The effect of Tan IIA on the protein and mRNA levels of Omentin-1 and ATP-binding cassette transporter A1 (ABCA1)...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Preterm Birth, Inflammation and Infection: New Alternative Strategies for their Prevention
Background: Worldwide, the progress in reducing neonatal mortality has been very slow. The rate of preterm birth has increased over the last 20 years in low-income and middle-income countries. Its association with increased mortality and morbidity is based on experimental studies and neonatal outcomes from countries with socioeconomic differences, which have considered implementing alternative healthcare strategies to prevent and reduce preterm births. Methods: Currently, there is no widely effective...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Microorganisms Isolated from Stored Meat in India, with Potential Antimicrobial Activity against Food Pathogens
Background: World Health Organization has estimated that 1 in 10 people fall ill and 4, 20, 000 die every year from eating contaminated food. Food pathogens like Escherichia, Salmonella, Staphylococcus and Listeria pose a serious threat to human health. Objective: The objective was to isolate microbes from meat stored at refrigerated conditions and evaluate the antimicrobial activity of the cell-free supernatant against food pathogens. Methods: Chicken and Pork samples were procured and stored...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
Background: Fenoldopam mesylate is a selective agonist of DA-1 receptors. It is currently used for the in-hospital treatment of severe hypertension. DA-1 receptors have high density in renal parenchyma and for this reason, a possible reno-protective role of Fenoldopam mesylate was investigated. Methods: We examined all studies regarding the role of Fenoldopam mesylate in Acute Kidney Injury (AKI); particularly, those involving post-surgical patients, intensive care unit patients and contrastinduced...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Amruthapala (Decalepis arayalpathra (J. Joseph and V. Chandras.) Venter): A Comprehensive Review on Diversity, Therapeutic Uses, and Valorization of Bioactive Constituents
Background: Decalepis arayalpathra (J. Joseph and V. Chandras.) Venter is used primarily for nutrition besides its therapeutic values. Traditional preparations/formulations from its tuber are used as a vitalizer and blood purifier drink. The folklore medicinal uses cover inflammation, cough, wound healing, antipyretic, and digestive system management. A comprehensive review of the current understanding of the plant is required due to emerging concerns over its safety and efficacy. Objective: The...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Molecular Docking of Natural Phenolic Compounds for the Screening of Urease Inhibitors
Background: Bacterial ureases have been the cause of various human and animal pathogenicity including hepatic encephalopathy, hepatic coma urolithiasis, gastric and peptic ulcers, pyelonephritis, and urinary catheter encrustation by the production of ammonia. Hence, in view of the side effects of existing drugs, there is a strong need to discover, more safe, effective and potent compounds for the treatment of infections caused by urease. Methods: For this purpose, several natural phenolic compounds...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Multi-walled Carbon Nanotubes Reinforced into Hollow Fiber by Chitosan Sol-gel for Solid/Liquid Phase Microextraction of NSAIDs from Urine Prior to HPLC-DAD Analysis
Background: The efficient analytical method for the analysis of nonsteroidal antiinflammatory drugs (NSAIDs) in a biological fluid is important for determining the toxicological aspects of such long-term used therapies. Methods: In the present work, multi-walled carbon nanotubes reinforced into a hollow fiber by chitosan sol-gel assisted-solid/ liquid phase microextraction (MWCNTs-HF-CA-SPME) method followed by the high-performance liquid chromatography-diode array detection (HPLC–DAD) was developed...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53
Phytochemical Analysis and Evaluation of Antimicrobial Activity of Peumus boldus, Psidium guajava, Vernonia polysphaera, Persea Americana, Eucalyptus citriodora Leaf Extracts and Jatropha multifida Raw Sap
Background: Currently, the treatment of infectious diseases has not always been successful due to the emergence of microbial resistance worldwide. Objectives: This study aimed to evaluate the antioxidant activity, content of total phenolic compounds and flavonoids, antifungal potential and antibacterial action of six medicinal plants found in the Cerrado, leaf extracts of Boldo (Peumus boldus), Goiaba (Psidium guajava), Assa-Peixe (Vernonia polysphaera), Abacate (Persea americana), Eucalipto (Eucalyptus...
Current Pharmaceutical Biotechnology (Volume 19 - Issue 15)
Sun Jun 30, 2019 13:53

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου